These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39344695)

  • 1. FAAH inhibitor URB597 shows anti-hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF
    Larauche M; Mulak A; Ha C; Million M; Arnett S; Germano P; Pearson JP; Currie MG; Taché Y
    Neurogastroenterol Motil; 2024 Dec; 36(12):e14927. PubMed ID: 39344695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system.
    Okine BN; Norris LM; Woodhams S; Burston J; Patel A; Alexander SP; Barrett DA; Kendall DA; Bennett AJ; Chapman V
    Br J Pharmacol; 2012 Oct; 167(3):627-40. PubMed ID: 22595021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways.
    Larauche M; Gourcerol G; Wang L; Pambukchian K; Brunnhuber S; Adelson DW; Rivier J; Million M; Taché Y
    Am J Physiol Gastrointest Liver Physiol; 2009 Jul; 297(1):G215-27. PubMed ID: 19407218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
    Starowicz K; Makuch W; Korostynski M; Malek N; Slezak M; Zychowska M; Petrosino S; De Petrocellis L; Cristino L; Przewlocka B; Di Marzo V
    PLoS One; 2013; 8(4):e60040. PubMed ID: 23573230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
    Spradley JM; Guindon J; Hohmann AG
    Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain.
    Hama AT; Germano P; Varghese MS; Cravatt BF; Milne GT; Pearson JP; Sagen J
    PLoS One; 2014; 9(5):e96396. PubMed ID: 24788435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
    Danandeh A; Vozella V; Lim J; Oveisi F; Ramirez GL; Mears D; Wynn G; Piomelli D
    Psychopharmacology (Berl); 2018 Nov; 235(11):3211-3221. PubMed ID: 30251159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents.
    Sakin YS; Dogrul A; Ilkaya F; Seyrek M; Ulas UH; Gulsen M; Bagci S
    Neurogastroenterol Motil; 2015 Jul; 27(7):936-44. PubMed ID: 25869205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.
    Kwilasz AJ; Abdullah RA; Poklis JL; Lichtman AH; Negus SS
    Behav Pharmacol; 2014 Apr; 25(2):119-29. PubMed ID: 24583930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain.
    Jhaveri MD; Richardson D; Robinson I; Garle MJ; Patel A; Sun Y; Sagar DR; Bennett AJ; Alexander SP; Kendall DA; Barrett DA; Chapman V
    Neuropharmacology; 2008 Jul; 55(1):85-93. PubMed ID: 18534634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on lipopolysaccharide-induced airway inflammation in mice.
    Abohalaka R; Bozkurt TE; Nemutlu E; Onder SC; Sahin-Erdemli I
    Pulm Pharmacol Ther; 2020 Jun; 62():101920. PubMed ID: 32416152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
    Jiang HX; Ke BW; Liu J; Ma G; Hai KR; Gong DY; Yang Z; Zhou C
    Anesth Analg; 2019 Aug; 129(2):587-597. PubMed ID: 29863609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain.
    Lomazzo E; Bindila L; Remmers F; Lerner R; Schwitter C; Hoheisel U; Lutz B
    Neuropsychopharmacology; 2015 Jan; 40(2):488-501. PubMed ID: 25100669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
    Slivicki RA; Xu Z; Mali SS; Hohmann AG
    Pharmacol Res; 2019 Apr; 142():267-282. PubMed ID: 30739035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The newly developed CRF1-receptor antagonists, NGD 98-2 and NGD 9002, suppress acute stress-induced stimulation of colonic motor function and visceral hypersensitivity in rats.
    Million M; Zhao JF; Luckey A; Czimmer J; Maynard GD; Kehne J; Hoffman DC; Taché Y
    PLoS One; 2013; 8(9):e73749. PubMed ID: 24040053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats.
    Biernacki M; Łuczaj W; Gęgotek A; Toczek M; Bielawska K; Skrzydlewska E
    Toxicol Appl Pharmacol; 2016 Jun; 301():31-41. PubMed ID: 27086176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
    J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.
    Bosier B; Muccioli GG; Lambert DM
    Br J Pharmacol; 2013 Jun; 169(4):794-807. PubMed ID: 22970888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain.
    Jhaveri MD; Richardson D; Kendall DA; Barrett DA; Chapman V
    J Neurosci; 2006 Dec; 26(51):13318-27. PubMed ID: 17182782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.